Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein
US7888313B2 · kind B2 · utility
5Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2007 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Mar 18, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
α2-macroglobulin-related agents for treating or preventing a fibrotic disorder associated with fibrillogenesis are disclosed along with methods for using the agents, as well as methods for producing agents suited for use in the disclosed methods for treating or preventing a fibrotic disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.